By creating the most complete and detailed genetic "map" of ... 1,000 human kidney samples and hundreds of thousands of ...

There’s also MZE782, an oral SCL6A19 inhibitor in a phase 1 trial with healthy volunteers and plans to pursue the drug in chronic kidney disease and phenylketonuria. From these raises ...